SLC22A3 and cancer: Thus, the uptake of oxaliplatin into the cancer cells via hOCT3 was suggested to be an important mechanism for its cytotoxicity, and the expression of hOCT3 in cancers was proposed to become a marker for including oxaliplatin in cancer chemotherapy.